Objectives: Pediatric primary adrenal insufficiency (PAI) etiologies beyond congenital adrenal hyperplasia (CAH) show regional variations. Given limited data from India, this study aims to describe the etiological profile, phenotype, and genotype of pediatric PAI in an Indian cohort.

Methods: We conducted a retrospective review of patients with PAI onset before 20 years of age from 1998 to 2023 at a single center. After excluding patients with inadequate data (n=20), CAH (n=218), and bilateral adrenalectomy (n=19), we analyzed demographic, clinical, biochemical, and genetic data of the remaining patients.

Results: Among 54 patients (45 probands), the median age at presentation was 6 years (range 0.1-19). Common clinical features included hyperpigmentation (90.7 %), adrenal crisis (33.3 %), and seizures (29.6 %). Mineralocorticoid deficiency was present in two-third patients including one patient each with , , and mutation. Adrenoleukodystrophy (ALD) was the most common cause (40 %), followed by ACTH resistance states (20 %), early steroidogenic defects (13.3 %), congenital adrenal hypoplasia (11.1 %), autoimmune causes (8.9 %), and tuberculosis (4.5 %). Genetics diagnosed 14/15 patients without phenotypic clues and confirmed diagnoses in 21 tested of 30 with phenotypic pointers (alacrimia in , hypoparathyroidism/candidiasis in autoimmune polyendocrine syndrome-1 and neurodeficit in ALD). Genetics differentiated mutation from suspected ALD in two siblings with neurological deficits. We identified seven novel gene variants. We report the first case of associated with 46,XY gonadal dysgenesis. Adrenal tuberculosis was a unique cause of pediatric PAI.

Conclusions: This study reveals diverse non-CAH pediatric PAI etiologies in India, emphasizing genetic testing's importance for precise diagnoses and suggests region-specific diagnostic algorithm.

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem-2024-0476DOI Listing

Publication Analysis

Top Keywords

non-cah pediatric
8
pediatric primary
8
primary adrenal
8
adrenal insufficiency
8
pai etiologies
8
congenital adrenal
8
pediatric pai
8
adrenal
6
pediatric
5
patients
5

Similar Publications

Context: Understanding long-term outcomes and patient satisfaction with feminizing genitoplasty (FG) in patients with differences of sexual development (DSD) is crucial for optimizing treatment protocols.

Objective: To evaluate long-term morphological and functional results and patients' satisfaction in a cohort of DSD patients submitted to FG.

Design: Cross-sectional and retrospective cohort study conducted from 1965 to 2016 with follow-up assessments.

View Article and Find Full Text PDF

Objectives: Pediatric primary adrenal insufficiency (PAI) etiologies beyond congenital adrenal hyperplasia (CAH) show regional variations. Given limited data from India, this study aims to describe the etiological profile, phenotype, and genotype of pediatric PAI in an Indian cohort.

Methods: We conducted a retrospective review of patients with PAI onset before 20 years of age from 1998 to 2023 at a single center.

View Article and Find Full Text PDF

Background: Primary adrenal insufficiency (PAI) is a rare but potentially life-threatening condition. Congenital adrenal hyperplasia (CAH) is the most common cause of PAI in children. To date, numerous non-CAH causes have been identified through genetic analysis but they remain poorly characterized.

View Article and Find Full Text PDF

Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.

Front Endocrinol (Lausanne)

May 2024

Department of Pediatric Endocrinology and Diabetes, School of Medicine, Marmara University, Istanbul, Türkiye.

Article Synopsis
  • Prenatal exposure to androgens can disrupt sexual development in individuals with a 46,XX chromosome pattern, commonly leading to disorders/differences in sex development (DSD).
  • The majority of these cases are due to congenital adrenal hyperplasia (CAH) resulting from 21-hydroxylase deficiency, but there are rare forms of CAH and other genetic factors that can also contribute to 46,XX DSD.
  • The management of 46,XX DSD is complex due to uncertainties regarding gonadal function and gender outcomes, making diagnosis and treatment challenging.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!